U.K. (FTSE) Clinical Research and Equipment Industry Analysis
UpdatedMay 08, 2024
DataAggregated Company Financials
Companies9
- 7D6.7%
- 3M-23.9%
- 1Y-42.5%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has risen 6.7%, driven by gains from Oxford Nanopore Technologies of 13%. However, the industry is down 43% over the past year. Earnings are forecast to grow by 14% annually.
Industry Valuation and Performance
Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 08 May 2024 | UK£1.6b | UK£292.9m | -UK£188,993,040.89 | 6867.6x | -8.3x | 5.4x |
| Fri, 05 Apr 2024 | UK£1.7b | UK£319.1m | -UK£191,357,589.21 | 70.4x | -8.9x | 5.3x |
| Sun, 03 Mar 2024 | UK£1.8b | UK£285.8m | -UK£189,240,511.01 | 6609.8x | -9.6x | 6.4x |
| Tue, 30 Jan 2024 | UK£2.7b | UK£450.2m | -UK£176,570,289.00 | 62.2x | -15.1x | 5.9x |
| Thu, 28 Dec 2023 | UK£3.2b | UK£449.8m | -UK£173,811,154.00 | 54.4x | -18.4x | 7.1x |
| Sat, 25 Nov 2023 | UK£3.0b | UK£455.4m | -UK£168,510,998.00 | 49.9x | -17.8x | 6.6x |
| Mon, 23 Oct 2023 | UK£3.1b | UK£458.7m | -UK£165,641,089.00 | 48.3x | -18.5x | 6.7x |
| Wed, 20 Sep 2023 | UK£3.0b | UK£440.6m | -UK£167,122,892.00 | 67.5x | -18.1x | 6.9x |
| Fri, 18 Aug 2023 | UK£3.1b | UK£476.1m | -UK£126,453,796.00 | 70.6x | -24.5x | 6.5x |
| Sun, 16 Jul 2023 | UK£3.0b | UK£475.6m | -UK£124,063,543.00 | 65.2x | -24.4x | 6.4x |
| Tue, 13 Jun 2023 | UK£3.1b | UK£477.2m | -UK£125,188,703.00 | 63.5x | -25x | 6.5x |
| Thu, 11 May 2023 | UK£3.2b | UK£479.8m | -UK£117,098,718.00 | 36.3x | -27.5x | 6.7x |
| Sat, 08 Apr 2023 | UK£3.0b | UK£458.8m | -UK£118,909,403.00 | 33.1x | -25.2x | 6.5x |
| Mon, 06 Mar 2023 | UK£3.1b | UK£443.7m | -UK£183,120,179.00 | 43.6x | -16.9x | 7x |
| Wed, 01 Feb 2023 | UK£3.4b | UK£442.9m | -UK£182,676,771.00 | 45.4x | -18.4x | 7.6x |
| Fri, 30 Dec 2022 | UK£3.4b | UK£443.6m | -UK£183,005,071.00 | 49.4x | -18.5x | 7.6x |
| Sun, 27 Nov 2022 | UK£3.6b | UK£446.7m | -UK£179,083,272.00 | 48.9x | -20x | 8x |
| Tue, 25 Oct 2022 | UK£3.4b | UK£449.3m | -UK£176,581,530.00 | 42.2x | -19.3x | 7.6x |
| Thu, 22 Sep 2022 | UK£3.7b | UK£430.2m | -UK£176,874,717.00 | 44.9x | -21x | 8.6x |
| Sat, 20 Aug 2022 | UK£4.0b | UK£369.5m | -UK£191,630,387.00 | 50.3x | -21x | 10.9x |
| Mon, 18 Jul 2022 | UK£3.5b | UK£367.2m | -UK£188,315,171.00 | 38.1x | -18.8x | 9.6x |
| Wed, 15 Jun 2022 | UK£3.8b | UK£364.5m | -UK£189,752,475.00 | 38.5x | -19.8x | 10.3x |
| Fri, 13 May 2022 | UK£3.4b | UK£361.8m | -UK£191,753,404.00 | 38.9x | -17.7x | 9.4x |
| Sun, 10 Apr 2022 | UK£6.4b | UK£930.0m | -UK£312,873,925.00 | 49x | -20.6x | 6.9x |
| Tue, 08 Mar 2022 | UK£6.3b | UK£891.9m | -UK£202,553,692.00 | 43.5x | -31x | 7x |
| Thu, 03 Feb 2022 | UK£7.7b | UK£848.8m | -UK£185,795,928.00 | 30.6x | -41.3x | 9x |
| Sat, 01 Jan 2022 | UK£9.8b | UK£849.0m | -UK£184,734,302.00 | 30.8x | -53.2x | 11.6x |
| Mon, 29 Nov 2021 | UK£8.8b | UK£844.1m | -UK£191,076,906.00 | 19.7x | -46.2x | 10.5x |
| Wed, 27 Oct 2021 | UK£7.3b | UK£819.7m | -UK£188,196,718.00 | 26.1x | -38.9x | 8.9x |
| Fri, 24 Sep 2021 | UK£3.1b | UK£690.4m | -UK£129,656,804.00 | 29.8x | -23.9x | 4.5x |
| Sun, 22 Aug 2021 | UK£2.9b | UK£670.4m | -UK£160,499,800.35 | 62.5x | -17.9x | 4.3x |
| Fri, 09 Jul 2021 | UK£3.0b | UK£670.4m | -UK£160,499,800.35 | 61.5x | -18.6x | 4.5x |
Price to Earnings Ratio
-40.4x
Current Industry PE
- Investors are pessimistic on the British Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 8.6x is higher than the industry's current PS ratio of 5.4x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 24% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does U.K. Clinical Research and Equipment compare with similar industries?
| GB Market | 1.96% | |
| Healthcare | 1.89% | |
| Life Sciences | 6.74% | |
| Clinical Research and Equipment | 6.74% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ONT Oxford Nanopore Technologies | UK£1.11 | 13.0% +UK£112.6m | -52.7% | PS5.6x | |
| ERGO Ergomed | UK£13.46 | 0.1% +UK£14.7m | 3.5% | PE46.7x | |
| C4XD C4X Discovery Holdings | UK£0.12 | 45.9% +UK£9.5m | -16.4% | PE2.9x | |
| FAB Fusion Antibodies | UK£0.034 | 5.4% +UK£166.9k | -91.5% | PS2.1x |